BIOMAT Database Logo BIOMAT Database Logo

Mice vaccinated with enteropathogenic Escherichia coli ghosts show significant protection against lethal challenges. 2012

J Liu, and W D Wang, and Y J Liu, and S Liu, and B Zhou, and L W Zhu, and X Ji, and Y Sun, and S Z Feng
Institute of Military Veterinary Science, Academy of Military Medical Sciences, Changchun, China.

OBJECTIVE To prepare enteropathogenic Escherichia coli (EPEC) E2348/69 ghosts and investigate whether immunization with EPEC bacterial ghosts can elicit protective immune responses. RESULTS A recombinant plasmid with double λPL/PR-cI857 temperature-sensitive regulatory cassettes was constructed. The lysis gene E and/or the staphylococcal nuclease A (SNA) gene were separately inserted downstream of the two regulatory cassettes to construct the lysis plasmids pBV220::E and pBV220::E::CI-P-SNA. An EPEC reference strain E2348/69 (serotype O127:H6) was transformed with the lysis plasmids to produce EPEC ghosts. Mice injected with bacterial ghosts EGE (EPEC ghosts produced using lysis protein E) or EGES (EPEC ghosts produced using a combination of lysis protein E and SNA) gained weight normally and showed no clinical signs of disease. Vaccination trials showed that mice immunized with EGE or EGES were significantly protected against subsequent challenge with the wild-type virulent parent strain, EPEC E2348/69 (42/50 and 45/50 survival, respectively); in contrast, none of the 30 control mice survived. CONCLUSIONS Immunization with EPEC ghosts can elicit protective immune responses in BALB/c mice. CONCLUSIONS EPEC ghosts may represent a promising new approach for vaccination against EPEC infection.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D005260 Female Females
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity

Related Publications

J Liu, and W D Wang, and Y J Liu, and S Liu, and B Zhou, and L W Zhu, and X Ji, and Y Sun, and S Z Feng
Protection of Mice against Lethal Staphylococcus Infection by Escherichia coli O86 Fractions.
August 1961, Science (New York, N.Y.),
J Liu, and W D Wang, and Y J Liu, and S Liu, and B Zhou, and L W Zhu, and X Ji, and Y Sun, and S Z Feng
Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge.
August 2005, Infection and immunity,
J Liu, and W D Wang, and Y J Liu, and S Liu, and B Zhou, and L W Zhu, and X Ji, and Y Sun, and S Z Feng
Passive protection of lambs against enteropathogenic Escherichia coli: role of antibodies in serum and colostrum of dams vaccinated with K99 antigen.
May 1980, Journal of medical microbiology,
J Liu, and W D Wang, and Y J Liu, and S Liu, and B Zhou, and L W Zhu, and X Ji, and Y Sun, and S Z Feng
Protection of rabbits against enteropathogenic Escherichia coli (EPEC) using an intimin null mutant.
June 2006, BMC veterinary research,
J Liu, and W D Wang, and Y J Liu, and S Liu, and B Zhou, and L W Zhu, and X Ji, and Y Sun, and S Z Feng
Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model.
June 2011, Infection and immunity,
J Liu, and W D Wang, and Y J Liu, and S Liu, and B Zhou, and L W Zhu, and X Ji, and Y Sun, and S Z Feng
Mice orally vaccinated with Edwardsiella tarda ghosts are significantly protected against infection.
March 2009, Vaccine,
J Liu, and W D Wang, and Y J Liu, and S Liu, and B Zhou, and L W Zhu, and X Ji, and Y Sun, and S Z Feng
Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.
April 2011, Vaccine,
J Liu, and W D Wang, and Y J Liu, and S Liu, and B Zhou, and L W Zhu, and X Ji, and Y Sun, and S Z Feng
Studies of active immunization against enteropathogenic Escherichia coli.
April 1962, Canadian Medical Association journal,
J Liu, and W D Wang, and Y J Liu, and S Liu, and B Zhou, and L W Zhu, and X Ji, and Y Sun, and S Z Feng
Protection against Shiga-Toxigenic Escherichia coli by Non-Genetically Modified Organism Receptor Mimic Bacterial Ghosts.
September 2015, Infection and immunity,
J Liu, and W D Wang, and Y J Liu, and S Liu, and B Zhou, and L W Zhu, and X Ji, and Y Sun, and S Z Feng
Enteropathogenic Escherichia coli.
October 1992, Infection and immunity,
Copied contents to your clipboard!